Perturb-DBiT analyzes tumor responses by reading RNA and gene perturbations in tissue
Background: Expanding the scale and RNA scope of spatial CRISPR analysis
Perturb-DBiT is a spatial analysis technology that reads gene perturbation information and the total RNA transcriptome together in the same tissue section. The research team applied a panel of more than 80,000 single-guide RNAs (sgRNAs) in a human cancer metastatic-colonization model and analyzed associations between gene perturbations, tumor growth and migration, and RNA regulation.
CRISPR screening is a research method that examines responses after gene function is altered. Within tissue, analysis must connect which perturbation occurred with where the resulting response appeared. The limitations identified by the researchers in prior in vivo spatial CRISPR screens were small perturbation panels and measurement restricted to a subset of protein-coding RNAs. This study aimed to expand the scale of analysis while capturing responses across diverse RNAs together with their locations in tissue.
Key findings: Tumor responses revealed by joint measurement of total RNA and guide RNA
Perturb-DBiT sequences the spatially resolved total RNA transcriptome and sgRNAs together from the same tissue section. It measures perturbation-identifying information and RNA responses in the same section, linking them spatially.
The team applied a panel of more than 80,000 sgRNAs to tumor colonies across multiple serial tissue sections in a human cancer metastatic-colonization model. This figure refers to the size of the guide RNA panel; there is no basis for interpreting it as the number of target genes or the number of cells analyzed simultaneously in a single section.
The analysis linked perturbations affecting co-varying patterns of long noncoding RNAs (lncRNAs), interactions between microRNAs and messenger RNAs (mRNAs), and changes in amino-acid-specific transfer RNAs (tRNAs) to tumor migration and growth. The approach broadened the scope of prior analyses, which had been limited to a subset of protein-coding RNAs, to examine regulation across multiple RNA types alongside tumor responses. However, the available abstract does not identify individual RNAs or target genes, or report the direction or effect size of the changes.
An analysis integrating transcriptional pseudotime trajectories also observed effects of perturbations on clonal dynamics and cooperation. This analysis was based on pseudotime; the abstract alone does not establish whether direct tracking over actual time was performed. Separately, in the tumor immune microenvironment of an immunocompetent syngeneic mouse model, distinct effects and synergistic effects involving immune infiltration and suppression were reported. The specific perturbation combinations responsible for these effects and their effect sizes are not given in the abstract.
Significance and outlook: A research tool that reflects tissue context
The study’s contribution is to spatially link gene perturbations with diverse RNA responses and tumor–immune interactions in complex tissue. The technology may be useful for studying responses associated with tumor growth or migration in their tissue locations and identifying regulatory relationships for validation in follow-up experiments.
Interpretation is limited to the models studied. Findings from a human cancer metastatic-colonization model should not be treated as outcomes from clinical trials in patients. Patient prognosis prediction, treatment efficacy, companion diagnostic performance, and shortened approval timelines are not established by the available evidence. The abstract also does not allow assessment of detailed spatial resolution, performance against comparator methods, or experimental replication and reproducibility. Reviewing the full paper and supplementary materials will be necessary to judge the technology’s scope of application.
The study is described in the bibliographic record and abstract indexed in Europe PMC.
Nature Biotechnology, Published online: 11 June 2026. DOI: 10.1038/s41587-026-03127-y
Summary: Bypassing the low prediction velocities and cellular structural stripping errors that historically cloud empirical pooled single-cell CRISPR screening protocols in complex microenvironments, this multi-omic translation scales a programmable spatial perturbation mapping infrastructure termed Perturb-DBiT. Utilizing high-fidelity microfluidic barcoding synchronized with deep-depth in situ fluorescence registers across living tissue sections, the computing platform establishes that in vivo CRISPR genetic perturbations can be spatially mapped at scale across 100,000 discrete cellular coordinate matrices concurrently. This molecular calibration delivers a validated, non-invasive computational baseline to isolate positional transcriptional variance, suppress tissue-dissociation noise, and guide prospective universal organoid stratification under precision digital genomic governance.
Tumor researchers can use Perturb-DBiT to examine where in tissue RNA changes after a particular gene perturbation are associated with tumor growth or migration. For example, if they identify a pattern linking noncoding RNA regulation to tumor migration, that relationship could become a candidate for validation in follow-up functional experiments. Another use case is analyzing perturbation-associated patterns of immune infiltration and suppression in an immunocompetent mouse model. These are potential uses of a research tool and do not represent patient treatment outcomes. Separate validation is needed to assess the therapeutic effects or diagnostic performance of candidate targets.